期刊文献+

AMPK激动剂AICAR通过阻滞细胞周期于G_0/G_1期抑制肺动脉平滑肌细胞增殖 被引量:3

AICAR Blocks the Proliferation of Pulmonary Artery Smooth Muscle Cells by Inhibition of Cell Cycle in G_0/G_1
下载PDF
导出
摘要 目的建立PDGF-BB诱导的原代大鼠肺动脉平滑肌细胞(pulmonary vascular smooth musclecells,PASMCs)的增殖细胞模型,通过AMPK激动剂AICAR干预,探讨AICAR对PASMCs细胞周期和增殖的影响及其机制,为肺血管重构防治寻找靶点。方法通过20ng/mlPDGF-BB刺激诱导PASMCs增殖建立细胞模型,采用AICAR(0.5mmol/L)干预PDGF-BB诱导的PASMCs增殖,Westernblot法检测总的和磷酸化的AMPK,CCK-8检测PASMCs增殖,流式细胞仪分析细胞周期,实时定量PCR(RT-PCR)检测cyclinDl、cyclinE、CDK2/4/6mRNA的表达。结果Westernblot法检测表明AICAR可以活化AMPK,CCK-8检测结果表明AICAR能够抑制PDGF-BB诱导的PASMCs增殖;流式细胞仪检测结果表明AICAR能够抑制细胞周期于G0/G1期,RT-PCR结果表明AICAR可以抑制cyclinDl、cyclinE、CDK2、CDK4和CDK6的mRNA的表达。结论AICAR通过抑制cy-clinDl、cyclinE、CDK2/4/6的mRNA表达阻滞细胞周期于G0/G1-S期,抑制PASMCs增殖。 Objective To establish the PDGF -BB -induced proliferation of rat pulmonary artery smooth muscle cells(PAbMGs) , and investigate the effects of the AMPK agonist AICAR on the cell cycle of PASMCs, in order to search new drugs for prevention of pulmo- nary vascular remodeling. Methods 20ng/ml PDGF - BB was used to induced the proliferation of PASMCs, and the effect of 0.5mmol/ L AICAR on the proliferation of PASMCs was observed. Western blot was used to detect the total and phosphorylated AMPK. The prolifer- ation of PASMCs was determined by CCK - 8. The mRNA expression of cyclinD1, cyclinE and CDK2/4/6 were detected by flow cytome- try analysis cell cycle, quantitative real - time PCR. Results Western blot results indicated AICAR could promote the activation of AMPK. CCK - 8 test results showed that AICAR blocked the proliferation of PASMCs induced by PDGF - BB. Flow cytometry analysis in- dicated that AICAR arrested the cell cycle in G0/G1 to S phase. RT - PCR results demonstrated that AICAR inhibited the mRNA expres- sion of cyclinD1, cyclinE and CDK2/4/6. Conclusion The AMPK agonist AICAR can block the proliferation of PASMCs induced through arrest cell cycle in Go/G1 - S phase by regulation the mRNA expression of cyclin D1, cyclinE, CDK2/4/6, and AICAR has a po- tential application in preventing pulmonary vascular remodeling.
出处 《医学研究杂志》 2015年第5期111-113,共3页 Journal of Medical Research
关键词 AMPK PDGF-BB 肺动脉平滑肌细胞 细胞周期 增殖 AMPK PDGF- BB Pulmonary artery smooth muscle cells Cell cycle Proliferation
  • 相关文献

参考文献14

  • 1Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension [J]. N Engl J Med, 2004, 351( 14): 1425-1436.
  • 2Banal S, Wolf Y, Golomb G, et al. PDGF - receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine [J]. Circulation, 1998, 97( 19): 1960-1969.
  • 3Chen C, Tang Y, Deng W, et al. Salidroside blocks the proliferation of pulmonary artery smooth muscle ceils induced by platelet? derived growth factor? BB [J]. Mol Med Rep, 2014, 10(2): 917 -922.
  • 4Hardie DG, Scott JW, Pan DA, et al. Management of cellular energy by the AMP -activated protein kinase system [ J ]. FEBS Lett, 2003, 546(1): 113-120.
  • 5Kemp BE, Stapleton D, Campbell D J, et al. AMP - activated protein kinase, super metabolic regulator [ J]. Biochem Soe Trans, 2003, 31 (Pt 1): 162-168.
  • 6Nagata D, Takeda R, Sara M, et al. AMP - activated protein kinase inhibits angiotensin lI - stimulated vascular smooth muscle cell prolif- eration [ J ]. Circulation, 2004, 110 (4) : 444 - 451.
  • 7MeCarty MF, Barroso - Aranda J, Contreras F. AMP - activated ki- nase may suppress NADPH oxidase activation in vascular tissues [ J ]. Med Hypotheses, 2009, 72(4): 468-470.
  • 8Imamura K, Ogura T, Kishimoto A, et al. Cell cycle regulation via p53 phosphorylation by a 5' - AMP activated protein kinase activator, 5 - aminoimidazole - 4 - carboxamide - 1 - beta - D - ribofurano- side, in a human hepatocellular carcinoma cell line [ J ]. Biochem Biophys Res Commun, 2001, 287(2): 562-567.
  • 9Huang X, Fan R, Lu Y, et al. Regulatory effect of AMP - activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies [J]. Mol Biol Rep, 2014, 41 (6) :4031 -4041.
  • 10Sakao S, Tatsumi K, Voelkel NF. Reversible or irreversible remode- ling in pulmonary arterial hypertension [ J ]. Am J Respir Cell Mol Bi- ol, 2010, 43(6) : 629 -634.

同被引文献35

  • 1Bouchard J, Aeharya A, Cerda J, et al. A prospective in- ternational multicenter study of AKI in the intensive care Unit[J]. Clin J Am Soc Nephrol,2015,10(8): 1324-1331.
  • 2Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients:The multina- tional AKI-EPI study[J]. Intensive Care Med, 2015,41 (8) : 1411-1423.
  • 3Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract,2012,120(4):c179- c184.
  • 4Meersch M,Schmidt C,Van Aken H,et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery[l]. PLo S One, 2014,9(10) :el 10865.
  • 5Endre ZH,Pickering JW. Acute kidney injury: Cell cycle arrest biomarkers win race for AKI diagnosis[J]. Nat Rev Nephrol, 2014,10(12) : 683-685.
  • 6Iwakura T,Fujigaki Y,Fujikura T,et al. Acquired resis- tance to rechallenge injury after acute kidney injury in rats is associated with cell cycle arrest in proximal tubule cells[J]. Am J Physiol Renal Physiol, 2016,3 l0 (9) : F872- F884.
  • 7Bell M, Larsson A, Venge P, et al. Assessment of cell-cy- cle arrest biomarkers to predict early and delayed acute kidney injury[]]. Dis Markers, 2015,2015 : 158658.
  • 8Azzalini L,Spagnoli V,Ly HQ. Contrast-induced nephropa- thy: From pathophysiology to preventive strategies[J]. ,Can J Cardiol,2016, 32(2) :247-255.
  • 9Molitoris BA. Therapeutic translation in acute kidney in- jury:The epithelial/endothelial axis[J]. J Clin Invest,2014, 124(6) : 2355-2363.
  • 10Keir I,Kellum JA. Acute kidney injury in severe sepsis: Pathophysiology,diagnosis,and treatment recommenda- tions[J]. J Vet Emerg Crit Care, 2015,25 (2) :200,209.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部